In non-MLL-rearranged leukemia, such as Npm1c/Flt3-ITD, we have also demonstrated a role for leukemia-specific interactions of COMPASS complexes with TFs resulting in altered accessibility at Stat5a and Runx2 loci and consequent transcriptional dysregulation [16]. This evidence concerns the gene RUNX2 and leukemia.